Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05338437 · ClinicalTrials.gov registry record · NA
NMES in HF Patients to Improve Functional Recovery Following Hospitalization
A NA study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05338437: Completed NA study, sponsored by University of Vermont Medical Center.
NCT05338437 is a NA study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05338437, a NA study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this research study is to understand whether an at-home exercise program started after hospitalization for HFpEF, and continuing for 4 weeks following discharge from the hospital, can preserve or improve physical function.
Primary Outcome
6 MW was developed to assess cardiopulmonary fitness in patients with lung and cardiac disease, and has been validated in heart failure patients. It assesses the distance that a patient can walk in 6 minutes time around a standard course.
Interventions
- DEVICE Neuromuscular electrical stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT05338437 record still lists
NCT05338437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Neuromuscular electrical stimulation is the first listed.
NCT05338437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05338437 about?
NCT05338437 is a clinical study titled "NMES in HF Patients to Improve Functional Recovery Following Hospitalization". The goal of this research study is to understand whether an at-home exercise program started after hospitalization for HFpEF, and continuing for 4 weeks following discharge from the hospital, can preserve or improve physical function.
What is the current status of trial NCT05338437?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-02-07. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT05338437?
The interventions under investigation include: Neuromuscular electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT05338437?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05338437's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI